Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
about
Inhibition of lung tumor growth in nude mice by siRNA(CD31) targeting PECAM-1.Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibitionSelection of peptide inhibitor to matrix metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1.DMPPQA, a novel angiogenesis inhibitor, induces apoptosis in human colon cancer HCT-116 cells and HUVECs.Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomasHypoxia and HIFs in regulating the development of the hematopoietic system.Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment.Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.Treatment of malignant effusion by oncolytic virotherapy in an experimental subcutaneous xenograft model of lung cancer.The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionSolena amplexicaulis induces cell cycle arrest, apoptosis and inhibits angiogenesis in hepatocarcinoma cells and HUVECs.Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.Oxygen tension plays a critical role in the hematopoietic microenvironment in vitro.Overexpression of Antiangiogenic Vascular Endothelial Growth Factor Isoform and Splicing Regulatory Factors in Oral, Laryngeal and Pharyngeal Squamous Cell CarcinomasThe role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review).Cellular communication promotes mammosphere growth and collective invasion through microtubule‑like structures and angiogenesis
P2860
Q33778468-EA25B7A1-D39B-40E1-8CA1-A025E1D6246DQ33826039-6D0A67EF-AAC9-4F37-903E-80D29014F98BQ34273423-DDC238A0-DEDF-4C79-8127-EEFA2E30B79EQ35057273-B194CB00-F8AB-4FB5-B784-300896D2D6CEQ35836386-683992FF-5694-4AAE-8217-2495D3A0C156Q36157832-9F311CA3-4D4A-4F17-BDDC-31B828C81A62Q36527237-A4CCB58F-3750-4AA7-9FC7-E232ACCE06C4Q36691508-73FEEFFA-1258-4EDF-A3BC-99EEFBB04EC1Q36823307-E6656C56-2403-496D-8875-0350C8559DBBQ36907325-F83008A2-4E47-4BED-950A-BB4FC5AF62B5Q38924599-44474F56-80B3-449A-BDC3-A4B633434169Q41636608-BA7E03AD-A00E-46A3-908E-449B59526472Q41834050-7D277D3F-0AE2-4A4A-B9F8-604293422A69Q47168379-3F22E858-E111-492F-A2BF-1C4E431C7960Q52564106-8982AC43-8D06-4D65-84F4-9125FC215BCFQ58777021-9C2DF793-C18B-4D91-8082-16EE8D36796A
P2860
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
@en
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
@nl
type
label
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
@en
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
@nl
prefLabel
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
@en
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
@nl
P2093
P2860
P1433
P1476
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab
@en
P2093
Bernd R Binder
Christoph C Zielinski
Eva-Maria Lackner
Gabriela V Kornek
Gerald W Prager
Maria-Theresa Krauth
Marina Poettler
Sabine Cerny-Reiterer
Sylvia Laffer
Wolfgang Lamm
P2860
P304
P356
10.1016/J.MOLONC.2010.01.002
P577
2010-01-07T00:00:00Z